Charles River Laboratories International, Inc. (CRL) vs DaVita Inc. (DVA)
A side-by-side comparison of Charles River Laboratories International, Inc. and DaVita Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 4, 2026. Differences are shown without an overall score or investment verdict.
CRL
Charles River Laboratories International, Inc.
$235.00HealthcareDelayed quote: Aug 4, 2026, 3:00 PM EDT
DVA
DaVita Inc.
$231.36HealthcareDelayed quote: Aug 4, 2026, 3:00 PM EDT
Total return — CRL vs DVA
growth of $100 · dividends reinvested · last 26yCRL +949.4%DVA +13096.0%DVA compounded faster
Log scale — wide-divergence pair
CRL DVA
CRL vs DVA: by the numbers
- •DVA is the larger company ($14.85B vs $11.32B market cap).
- •DVA is profitable (5.65% net margin) while CRL runs a net loss (-4.59%).
- •CRL grew revenue faster over the past five years (5.77% vs 3.71% CAGR).
Metrics side by side
Valuation
| Metric | CRL | DVA |
|---|---|---|
| P/E ratio | N/A | 23.51 |
| Forward P/E | 20.79 | 15.70 |
| P/S ratio | 2.81 | 1.16 |
| P/B ratio | 3.84 | N/A |
| PEG ratio | N/A | 2.85 |
| EV / EBITDA | 17.19 | 10.23 |
| FCF yield | 3.46% | 9.28% |
Profitability
| Metric | CRL | DVA |
|---|---|---|
| Gross margin | 31.86% | 31.10% |
| Operating margin | 11.77% | 15.01% |
| Net margin | -4.59% | 5.65% |
| ROE | -6.28% | -114.70% |
| ROIC | 8.36% | 10.58% |
Growth (annualized)
| Metric | CRL | DVA |
|---|---|---|
| Revenue CAGR (5Y) | 5.77% | 3.71% |
| EPS CAGR (5Y) | -47.86% | 8.25% |
| FCF CAGR (5Y) | 6.43% | 6.13% |
| Total return CAGR (5Y) | -10.91% | 13.67% |
Frequently asked
- Which has grown faster, CRL or DVA?
- Over the past five years, CRL grew revenue faster — CRL at a 5.77% CAGR versus DVA at 3.71%.
- Is CRL or DVA more profitable?
- DVA runs the higher net margin — CRL at -4.59% versus DVA at 5.65%.
- How have CRL and DVA total returns compared?
- Over the past 10 years, CRL delivered 10.39% and DVA delivered 11.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Charles River Laboratories International P/E ratioDaVita P/E ratioCharles River Laboratories International dividend yieldDaVita dividend yieldCharles River Laboratories International ROEDaVita ROECharles River Laboratories International operating marginDaVita operating marginCharles River Laboratories International revenue growthDaVita revenue growthCharles River Laboratories International free cash flowDaVita free cash flow
Charles River Laboratories International & DaVita appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 4, 2026.